Parameter | Outcomes |
|
Age (years) |
|
|
| Median, (IQR) | 25 (22 - 30) |
| 15 - 20 n, (%) | 7 (15.55) |
| 20 - 35 n, (%) | 19 (42.22) |
| 25 - 30 n, (%) | 10 (22.22) |
| 30 - 35 n, (%) | 8 (17.77) |
| 35 - 40 n, (%) | 1 (2.22) |
Marital status |
|
|
| Single n, (%) | 2 (4.4) |
| Married n, (%) | 34 (75.6) |
| Divorced, n, (%) | 9 (20) |
Parity |
|
|
| Nulliparous, n, (%) | 6 (13.3) |
| Primipare n, (%) | 15 (33.3) |
| Multipare n, (%) | 24 (53.3) |
ART regimen |
|
|
| TDF + 3TC or FTC + EFV n, (%) | 34 (75.6) |
| AZT + 3TC + NVP n, (%) | 10 (22.2) |
| AZT + 3TC + LPV/r n, (%) | 1 (2.2) |
|
|
|
CD4 count (cell/mm3) |
|
|
at ART initiation | Median (IQR) | 249 (95 - 674) |
| <200 n, (%) | 19 (42.22) |
| 200 < CD4 < 500 n, (%) | 24 (53.3) |
| >500 n, (%) | 2 (4.4) |
at sample time | Median (IQR) | 530 (263 - 1220) |
| <200 n, (%) | 0 |
| 200 < CD4 < 500 n, (%) | 27 (60) |
| >500 n, (%) | 18 (40) |
Viral Load (VL) |
|
|
VL distribution at sample time | Median (IQR) copies/ml | 184 (86 - 400) |
| VL < 50 copies/ml n (%) | 7 (15.55) |
| 50 < VL < 1000 copies /ml n (%) | 34 (75.55) |
| VL > 1000 copies/ml n (%) | 4 (8.8) |